Frequency of beryllium and mycobacterial specific blood CD4+ T-cells in patients with sarcoidosis Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008
Late Breaking Abstract - Characterization of the immunological profile of COVID-19 patients and correlation of CD4+ and CD8+ T lymphocytes with disease severity during hospitalization. Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021
Mucosal CD4 and CD8 positive cells are associated with lung function decline after 7/8 years of follow-up in asthma patients Source: Eur Respir J 2002; 20: Suppl. 38, 589s Year: 2002
High percentage of CD8+ effector T lymphocytes in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002
Systemic CD4+ and CD8+ T-cell cytokine profiles correlate with GOLD stage in stable COPD Source: Eur Respir J 2012; 40: 330-337 Year: 2012
The role of increasing TIM3 on T cells in patients with nontuberculous mycobacterial lung disease: from immune cell dysfunction to clinical severity Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021
CMV- and EBV-specific CD8+ T cell responses in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 828s Year: 2006
CD4+CD25+ T lymphocytes in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 319s Year: 2004
Prognostic value of CD4 and CD8 T-cells in the development of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 328s Year: 2005
The declined CD4+ CD25+Treg cells in patients with moderate to severe asthma associated with over-expressed Th2 response Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012
CD4+/CD8+ T-cells ratio in patients with pulmonary tuberculosis Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease Year: 2012
Lung function decline in asthma patients with elevated bronchial CD8, CD4 and CD3 cells Source: Eur Respir J 2016; 48: 393-402 Year: 2016
Fas positive CD8+ lymphocytes in peripheral blood of patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005
Tumour-infiltrating CD8+ cells expressing IL-10, but not CD8+, CD4+ and CD68+ cells, are associated with a better prognosis in patients with NSCLC Source: Annual Congress 2008 - Airway cell biology Year: 2008
Decreased TCR γδ T lymphocytes in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003
Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking Source: Eur Respir J 2007; 29: 42-50 Year: 2007
The prognostic value of CD8+ and CD25+ lymphocytes blood content for asthma exacerbation Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012
Immunohistochemical analysis of T lymphocytes (TLs) in lung tissue from patients with idiopathic pulmonary fibrosis (IPF) suggests potential role of CD8+ TLs in lung injury Source: Eur Respir J 2004; 24: Suppl. 48, 46s Year: 2004
CD4+ and CD8+ T lymphocytes display a Th2/Tc2 cytokine profile in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 319s Year: 2004
Phenotypically aberrant and clonal T cell in the lung of patients with refractory coeliac disease Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013